RelB is a potential molecular biomarker for immunotherapy in human pan-cancer.
Front Mol Biosci
; 10: 1178446, 2023.
Article
in En
| MEDLINE
| ID: mdl-37388242
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Front Mol Biosci
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland